Caribou Biosciences, Inc. (CRBU) Net margin 2019–2025
Caribou Biosciences, Inc. (CRBU) net profit margin by fiscal year — reported net income divided by reported revenue.
-1327.4%FY2025 · since FY2019: -404.8% → -1327.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1327.4% | +164.5 pp |
| FY2024 | -1491.9% | -1195.9 pp |
| FY2023 | -296.1% | +421.7 pp |
| FY2022 | -717.8% | -20.5 pp |
| FY2021 | -697.3% | -419.7 pp |
| FY2020 | -277.6% | +127.3 pp |
| FY2019 | -404.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CRBU financial trends
CRBU RevenueCRBU Net incomeCRBU Gross profitCRBU Gross marginCRBU Operating incomeCRBU Operating marginCRBU Operating cash flowCRBU Free cash flowCRBU Capital expendituresCRBU Return on equityCRBU Stock buybacksCRBU Dividends paidCRBU Total assetsCRBU Total liabilitiesCRBU Shareholders’ equityCRBU overview →